Medicines & trials
Diabetes
Cardiovascular disease
Mar 12, 2024
Systemic metabolic markers and myocardial glucose uptake in type 2 diabetic and coronary artery disease patients treated for 16 weeks with rosiglitazone, a PPARγ agonist
R. Badeau et. al, Annals of Medicine, 2013